Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
SUN HEALTHCARE GROUP INC (SUNH)
|
Add to portfolio |
|
|
|
| Price: |
$3.08
| | Metrics |
| OS: |
25.5
|
M
| |
|
% ROE
|
| Market cap: |
$78.7
|
M
| |
20
|
% ROIC
|
|
Net debt:
|
$25.1
|
M
| |
0.2
|
x Debt/EBITDA
|
|
EV:
|
$104
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$111
|
M
| |
0.9
|
x EV/EBITDA
|
|
EBIT
|
$78.7
|
M
| |
1.3
|
x EV/EBIT
|
| EPS |
$0.33
| |
9.4
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| Revenues | 1,930.3 | 1,896.5 | 1,868.9 | 1,822.8 | 1,557.8 | 983.2 | 726.8 | 700.9 |
| Revenue growth | 1.8% | 1.5% | 2.5% | 17.0% | 58.4% | 35.3% | 3.7% | -10.0% |
| Cost of goods sold | 1,086.1 | 1,100.9 | 1,049.9 | 1,027.9 | 888.1 | 572.8 | 445.8 | 418.6 |
| Gross profit | 844.2 | 795.6 | 819.1 | 794.9 | 669.7 | 410.4 | 281.0 | 282.2 |
| Gross margin | 43.7% | 42.0% | 43.8% | 43.6% | 43.0% | 41.7% | 38.7% | 40.3% |
| General and administrative | 52.0 | 51.9 | 50.9 | 113.5 | 104.8 | 77.8 | 70.7 | 65.5 |
| EBITA | 20.5 | -13.3 | 23.6 | 120.8 | 90.7 | 29.6 | 15.2 | 6.1 |
| EBITA margin | 1.1% | -0.7% | 1.3% | 6.6% | 5.8% | 3.0% | 2.1% | 0.9% |
| Amortization of intangibles | | | | | | | 5.1 | 4.4 |
| EBIT | 20.5 | -13.3 | 23.6 | 120.8 | 90.7 | 29.6 | 10.1 | 1.7 |
| EBIT margin | 1.1% | -0.7% | 1.3% | 6.6% | 5.8% | 3.0% | 1.4% | 0.2% |
| Pre-tax income | -277.1 | 0.2 | 72.6 | 67.2 | 43.2 | 11.2 | -3.1 | 0.5 |
| Income taxes | 12.5 | 3.0 | 29.6 | -47.3 | -10.9 | -0.2 | -0.8 | -1.2 |
| Tax rate | | 1610.9% | 40.8% | | | | 25.3% | |
| Earnings from continuing ops | -289.6 | -2.8 | 43.0 | 114.5 | 54.1 | 11.4 | -2.3 | 1.7 |
| Earnings from discontinued ops | -2.2 | -1.9 | -4.3 | -5.2 | 3.4 | 15.7 | 18.2 | -15.0 |
| Net income | -291.8 | -4.7 | 38.7 | 109.3 | 57.5 | 27.1 | 24.8 | -18.6 |
| Net margin | -15.1% | -0.2% | 2.1% | 6.0% | 3.7% | 2.8% | 3.4% | -2.7% |
| |
| Diluted EPS | ($11.10) | ($0.14) | $2.92 | $7.60 | $1.25 | $0.36 | ($0.14) | $0.12 |
| Shares outstanding (diluted) | 26.1 | 19.3 | 14.7 | 15.1 | 43.4 | 31.8 | 16.0 | 14.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|